Heme - Chemo Drugs - Pharm
Terms
undefined, object
copy deck
-
S-phase-specific antimetabolite. Folic acid analog that inhibits dihydrofolate
reductase, resulting in ↓ dTMP and therefore ↓ DNA and protein synthesis. - Methotrexate (MTX)
-
Leukemias, lymphomas, choriocarcinoma, sarcomas. Abortion, ectopic pregnancy,
rheumatoid arthritis, psoriasis. - Methotrexate (MTX)
-
Myelosuppression, which is reversible with leucovorin (folinic acid) “rescue.â€
Macrovesicular fatty change in liver. - Methotrexate (MTX)
-
S-phase-specific antimetabolite. Pyrimidine analog bioactivated to 5F-dUMP, which
covalently complexes folic acid. This complex inhibits thymidylate synthase, resulting
in ↓ dTMP - 5-fluorouracil (5-FU)
-
Colon cancer and other solid tumors, basal cell carcinoma (topical). Synergy with
MTX. - 5-fluorouracil (5-FU)
- Myelosuppression, which is NOT reversible with leucovorin; photosensitivity.
- 5-fluorouracil (5-FU)
- Blocks de novo purine synthesis. Activated by HGPRTase.
- 6-mercaptopurine (6-MP)
- Leukemias, lymphomas (not CLL or Hodgkin’s).
- 6-mercaptopurine (6-MP)
- Bone marrow, GI, liver. Metabolized by xanthine oxidase; thus ↑ toxicity with allopurinol.
- 6-mercaptopurine (6-MP)
- Inhibits DNA polymerase.
- Cytarabine (ara-C)
- AML.
- Cytarabine (ara-C)
- Leukopenia, thrombocytopenia, megaloblastic anemia.
- Cytarabine (ara-C)
-
Alkylating agents; covalently x-link (interstrand) DNA at guanine N-7. Require
bioactivation by liver. - Cyclophosphamide, ifosfamide
- Non-Hodgkin’s lymphoma, breast and ovarian carcinomas. Also immunosuppressants.
- Cyclophosphamide, ifosfamide
- Myelosuppression; hemorrhagic cystitis, which can be partially prevented with mesna.
- Cyclophosphamide, ifosfamide
- Names of Nitrosoureas
- Carmustine, lomustine, semustine, streptozocin.
- Alkylate DNA. Require bioactivation. Cross blood-brain barrier → CNS.
-
Nitrosoureas
Carmustine, lomustine, semustine, streptozocin. - Brain tumors (including glioblastoma multiforme).
-
Nitrosoureas
Carmustine, lomustine, semustine, streptozocin. - CNS toxicity (dizziness, ataxia).
-
Nitrosoureas
Carmustine, lomustine, semustine, streptozocin. - Act like alkylating agents.
- Cisplatin, carboplatin
- Testicular, bladder, ovary, and lung carcinomas.
- Cisplatin, carboplatin
- Nephrotoxicity and acoustic nerve damage.
- Cisplatin, carboplatin
- Alkylates DNA.
- Busulfan
- CML.
- Busulfan
- Pulmonary fibrosis, hyperpigmentation.
- Busulfan
-
Generate free radicals and noncovalently intercalate in DNA (creating breaks in DNA
strand to ↓ replication). - Doxorubicin (Adriamycin), daunorubicin
-
Part of the ABVD combination regimen for Hodgkin’s and for myelomas, sarcomas, and
solid tumors (breast, ovary, lung). - Doxorubicin (Adriamycin), daunorubicin
- Cardiotoxicity; also myelosuppression and marked alopecia. Toxic extravasation.
- Doxorubicin (Adriamycin), daunorubicin
- Intercalates in DNA.
- Dactinomycin (actinomycin D)
- Wilms’ tumor, Ewing’s sarcoma, rhabdomyosarcoma.
- Dactinomycin (actinomycin D)
- Myelosuppression.
- Dactinomycin (actinomycin D)
- Induces formation of free radicals, which cause breaks in DNA strands.
- Bleomycin
- Testicular cancer, lymphomas (part of the ABVD regimen for Hodgkin’s).
- Bleomycin
- Pulmonary fibrosis, skin changes, but minimal myelosuppression.
- Bleomycin
- G2-phase-specific agent that inhibits topoisomerase II and ↑ DNA degradation.
- Etoposide (VP-16)
- Small cell carcinoma of the lung and prostate, testicular carcinoma.
- Etoposide (VP-16)
- Myelosuppression, GI irritation, alopecia.
- Etoposide (VP-16)
- May trigger apoptosis. May even work on nondividing cells.
- Prednisone
- Most commonly used glucocorticoid in cancer chemotherapy. Used in CLL, Hodgkin’s lymphomas (part of the MOPP regimen). Also an immunosuppressant used in autoimmune diseases.
- Prednisone
- Cushing-like symptoms; immunosuppression, cataracts, acne, osteoporosis, hypertension, peptic ulcers, hyperglycemia, psychosis.
- Prednisone
- Estrogen receptor mixed agonist/antagonists (“SERMsâ€) that block the binding of estrogen to estrogen receptor–positive cells.
- Tamoxifen, raloxifene
- Breast cancer. Also useful to prevent osteoporosis.
- Tamoxifen, raloxifene
- _______ may ↑ the risk of endometrial carcinoma via partial agonist effects; “hot flashes.â€
- Tamoxifen, raloxifene
- Monoclonal antibody against HER-2 (erb-B2). Helps kill breast cancer cells that overexpress HER-2, possibly through antibody-dependent cytotoxicity.
- Trastuzumab (Herceptin)
- Metastatic breast cancer.
- Trastuzumab (Herceptin)
- Cardiotoxicity.
- Trastuzumab (Herceptin)
- Myoclonal antibody against the Philadelphia chromosome brc-abl tyrosine kinase.
- Imatinib (Gleevec)
- CML, GI stromal tumors.
- Imatinib (Gleevec)
- Fluid retention.
- Imatinib (Gleevec)
- M-phase-specific alkaloids that bind to tubulin and block polymerization of microtubules so that mitotic spindle cannot form.
- Vincristine, vinblastine
-
Part of the MOPP regimen for lymphoma, Wilms’ tumor,
choriocarcinoma. - (Oncovin [vincristine] is part of MOPP), vinblastine
- neurotoxicity (areflexia, peripheral neuritis), paralytic ileus.
- Vincristine
- Bone marrow suppression
- VinBLASTine BLASTs Bone marrow (suppression).
- M-phase-specific agents that bind to tubulin and hyperstabilize polymerized microtubules so that mitotic spindle cannot break down (anaphase cannot occur).
- Paclitaxel, other taxols
- Ovarian and breast carcinomas.
- Paclitaxel, other taxols
- Myelosuppression and hypersensitivity.
- Paclitaxel, other taxols